0001628280-21-014218.txt : 20210721
0001628280-21-014218.hdr.sgml : 20210721
20210721205305
ACCESSION NUMBER: 0001628280-21-014218
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210721
FILED AS OF DATE: 20210721
DATE AS OF CHANGE: 20210721
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Casdin Partners GP, LLC
CENTRAL INDEX KEY: 0001534260
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40646
FILM NUMBER: 211105745
BUSINESS ADDRESS:
STREET 1: 1350 AVENUE OF THE AMERICAS
STREET 2: SUITE 1140
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 212.300.5575
MAIL ADDRESS:
STREET 1: 1350 AVENUE OF THE AMERICAS
STREET 2: SUITE 1140
CITY: NEW YORK
STATE: NY
ZIP: 10019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Casdin Capital, LLC
CENTRAL INDEX KEY: 0001534261
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40646
FILM NUMBER: 211105746
BUSINESS ADDRESS:
STREET 1: 1350 AVENUE OF THE AMERICAS
STREET 2: SUITE 2600
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 212.300.5575
MAIL ADDRESS:
STREET 1: 1350 AVENUE OF THE AMERICAS
STREET 2: SUITE 2600
CITY: NEW YORK
STATE: NY
ZIP: 10019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC
CENTRAL INDEX KEY: 0001864554
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40646
FILM NUMBER: 211105743
BUSINESS ADDRESS:
STREET 1: 1350 AVENUE OF THE AMERICAS
STREET 2: SUITE 2600
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 212-897-5430
MAIL ADDRESS:
STREET 1: 1350 AVENUE OF THE AMERICAS
STREET 2: SUITE 2600
CITY: NEW YORK
STATE: NY
ZIP: 10019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Casdin Partners Master Fund, L.P.
CENTRAL INDEX KEY: 0001534265
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40646
FILM NUMBER: 211105747
BUSINESS ADDRESS:
STREET 1: WALKER HOUSE
STREET 2: 87 MARY STREET
CITY: GEORGE TOWN
STATE: E9
ZIP: KY1-9001
BUSINESS PHONE: 212.300.5575
MAIL ADDRESS:
STREET 1: WALKER HOUSE
STREET 2: 87 MARY STREET
CITY: GEORGE TOWN
STATE: E9
ZIP: KY1-9001
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Casdin Private Growth Equity Fund, L.P.
CENTRAL INDEX KEY: 0001823061
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40646
FILM NUMBER: 211105744
BUSINESS ADDRESS:
STREET 1: 1350 AVENUE OF THE AMERICAS
STREET 2: SUITE 2600
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 212-897-5430
MAIL ADDRESS:
STREET 1: 1350 AVENUE OF THE AMERICAS
STREET 2: SUITE 2600
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER NAME:
FORMER CONFORMED NAME: CASDIN PRIVATE GROWTH EQUITY FUND, L.P.
DATE OF NAME CHANGE: 20200831
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Absci Corp
CENTRAL INDEX KEY: 0001672688
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 453931977
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18105 SE MILL PLAIN BLVD
CITY: VANCOUVER
STATE: WA
ZIP: 98683
BUSINESS PHONE: (360) 949-1041
MAIL ADDRESS:
STREET 1: 18105 SE MILL PLAIN BLVD
CITY: VANCOUVER
STATE: WA
ZIP: 98683
FORMER COMPANY:
FORMER CONFORMED NAME: AbSci Corp
DATE OF NAME CHANGE: 20201026
FORMER COMPANY:
FORMER CONFORMED NAME: AbSci, Inc.
DATE OF NAME CHANGE: 20201026
FORMER COMPANY:
FORMER CONFORMED NAME: AbSci, LLC
DATE OF NAME CHANGE: 20160420
3
1
wf-form3_162691516805201.xml
FORM 3
X0206
3
2021-07-21
0
0001672688
Absci Corp
ABSI
0001534265
Casdin Partners Master Fund, L.P.
1350 AVENUE OF THE AMERICAS, SUITE 2600
NEW YORK
NY
10019
1
0
1
0
0001534261
Casdin Capital, LLC
1350 AVENUE OF THE AMERICAS, SUITE 2600
NEW YORK
NY
10019
1
0
1
0
0001534260
Casdin Partners GP, LLC
1350 AVENUE OF THE AMERICAS, SUITE 2600
NEW YORK
NY
10019
1
0
1
0
0001823061
Casdin Private Growth Equity Fund, L.P.
1350 AVENUE OF THE AMERICAS, SUITE 2600
NEW YORK
NY
10019
1
0
1
0
0001864554
CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC
1350 AVENUE OF THE AMERICAS, SUITE 2600
NEW YORK
NY
10019
1
0
1
0
Series E Preferred Stock
Common Stock
4209573.0
D
Convertible Note
13.12
Common Stock
973260.0
D
Convertible Note
13.12
Common Stock
973260.0
I
By Casdin Private Growth Equity Fund, L.P.
These shares of the Issuer's Series E Preferred Stock will automatically convert on a one-for-3.3031 basis into the number of shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), shown in Column 3 immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series E Preferred Stock has no expiration date.
These shares are held by Casdin Partners Master Fund, L.P. Casdin Capital, LLC ("Casdin Capital") is the investment adviser to Casdin Partners Master Fund, L.P., and Casdin Partners GP, LLC ("Casdin Partners GP") is the general partner of Casdin Partners Master Fund, L.P. Eli Casdin is the managing member of Casdin Capital and Casdin Partners GP. Each of Casdin Capital, Casdin Partners GP and Eli Casdin disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interest therein, if any. Eli Casdin is a director of the Issuer and, accordingly, files separate Section 16 reports.
This convertible promissory note ("Convertible Note") has a maturity date of September 16, 2023. The principal and accrued interest under the Convertible Note will convert upon the closing of the IPO into shares of Common Stock at a conversion price equal to $13.12 per share without payment of additional consideration.
These shares are held by Casdin Private Growth Equity Fund, L.P. Casdin Capital is the investment adviser to Casdin Private Growth Equity Fund, L.P. and Casdin Private Growth Equity Fund GP, LLC ("Casdin Private Growth GP") is the general partner of Casdin Private Growth Equity Fund, L.P. Eli Casdin is the managing member of Casdin Capital and Casdin Private Growth GP. Each of Casdin Capital, Casdin Private Growth GP and Eli Casdin disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interest therein, if any. Eli Casdin is a director of the Issuer and, accordingly, files separate Section 16 reports.
Eli Casdin has been deputized to represent the Reporting Persons on the board of directors of the Issuer. By virtue of Mr. Casdin's representation, for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act"), each of the Reporting Persons may be deemed directors by deputization of the Issuer. Mr. Casdin files separate Section 16 reports disclosing securities of the Issuer that he may be deemed to beneficially own for Section 16 purposes.
Casdin Partners Master Fund, L.P., By: Casdin Partners GP, LLC, Its: General Partner, By: /s/ Eli Casdin, Its: Managing Member
2021-07-21
Casdin Capital, LLC, By: /s/ Eli Casdin, Its: Managing Member
2021-07-21
Casdin Partners GP LLC, By: /s/ Eli Casdin, Its: Managing Member
2021-07-21
Casdin Private Growth Equity Fund, L.P., By: Casdin Private Growth Equity Fund GP, LLC, By: /s/ Eli Casdin, Its: Managing Member
2021-07-21
Casdin Private Growth Equity Fund GP, LLC, By: /s/ Eli Casdin, Its: Managing Member
2021-07-21